Skip to main content
. 2021 Dec 14;10(24):5857. doi: 10.3390/jcm10245857

Figure 3.

Figure 3

Significant reduction of episodes of delirium in the group treated with melatonin PRM 2 mg: 30% episodes in the median versus 37.5% episodes in the untreated group.